Jefferies initiates Altria stock with Underperform rating, cites combustibles risk

Investing.com

Published Jul 09, 2025 01:30AM ET

Jefferies initiates Altria stock with Underperform rating, cites combustibles risk

Investing.com - Jefferies initiated coverage on Altria Group (NYSE:MO) with an Underperform rating and a $50.00 price target on Wednesday. The stock currently trades at $59.54, near its 52-week high of $61.26, with InvestingPro data showing impressive gross profit margins of 71%.

The research firm expressed concern about risks to Altria's U.S. combustibles business, pointing to accelerated high-single-digit volume declines and additional pressure from consumer downtrading.

Jefferies noted that Altria's market-leading position in declining traditional oral tobacco products is offsetting growth in modern oral products.

The firm projects slower cash returns growth for Altria compared to peers British American Tobacco (NYSE:BTI) and Imperial Brands (OTC:IMBBY), which Jefferies believes have "a firmer footing."

Jefferies highlighted the valuation disparity, noting Altria trades at a calendar 2026 price-to-earnings ratio of 11.5x, compared to British American Tobacco at 9.5x and Imperial Brands at 8.5x.

In other recent news, Altria Group has seen a series of significant developments. UBS upgraded Altria's stock rating from Sell to Neutral, citing improved prospects due to increased enforcement against illicit vape products. This change is supported by a 40% decline in vape exports from China to the U.S., which has benefited Altria by potentially stabilizing cigarette volume decline. In corporate moves, Altria announced a temporary suspension of trading under its employee benefit plans due to a transition in trustee services, affecting various employee accounts. Additionally, Altria appointed Katie F. Patterson as the new Vice President and Controller, effective August 1, 2025, following the retirement of Steven D'Ambrosia. During its Annual Meeting of Shareholders, Altria approved key financial plans and executive compensation, including the 2025 Performance Incentive Plan and the 2025 Stock Compensation Plan for Non-Employee Directors. The company also declared a quarterly dividend of $1.02 per share, scheduled for payment on July 10, 2025. Furthermore, a joint operation by the FDA and U.S. Customs led to the seizure of nearly two million units of illegal e-cigarettes, valued at $34 million, which aligns with Altria's interests in combating unauthorized vape products.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes